The Best Marijuana Stocks Right Now
Zacks Investment Research | Mar 13, 2018 11:06PM ET
Back in early 2017, the investment pickings were slim.
Have things changed in 2018?
Maturing of the Pot Stock Industry
Demand remains high for “pot stocks.” For that reason, several marijuana ETFs have now launched and more businesses are looking for ways to get a foothold in the industry.
In addition to the stocks they talked about last year, Tracey and Dave also found several more investing options.
They focused on those that are traded on the US exchanges and have, or soon will have, Zacks Rank. That means some stocks that trade on the Pink Sheets, like Aurora Cannabis (ACBFF) for example, are not high on their list even though it has a $4.4 billion market cap.
5 Stocks that get you into the Marijuana Trade
1. The Scotts Miracle-Gro Company (NYSE:SMG) making potting soil specifically for growing marijuana. While it was a stock mentioned on the 2017 podcast, its performance hasn’t been that great. Shares have fallen 2.3% in that time.
2. GW Pharmaceuticals (NASDAQ:GWPH) is a British biopharmaceutical company that is developing cannabis medicines. It’s lead product is in development to treat rare and catastrophic forms of childhood on-set epilepsy. It’s expected to lose $8.95 per share in fiscal 2018 and another $6.12 in fiscal 2019. Shares are up just 1% since the January 2017 podcast.
3. Innovative Industrial Properties (NYSE:IIPR) is a REIT that manages free-standing properties for growing licensed medical-use cannabis. These facilities are operated by state licensed growers. It has buildings in New York, Maryland, Minnesota and just acquired a site in Arizona which has a long-term lease. Earnings are expected to be $0.19 in 2017 and $1.32 in 2018. It has paid out a distribution in 2017. Shares are up 44% since the Jan 17, 2017 podcast.
4. AbbVie (NYSE:ABBV) is a large cap US biopharmaceutical company which just happens to be one of the first with an FDA approved cannabis-based drug, Marinol, on the market. Marinol is approved for chemotherapy induced nausea and vomiting and anorexia. AbbVie is expected to grow earnings by 33% in 2018 yet trades with a forward P/E of just 15.8.
5. Cronos Group (NASDAQ:CRON) listed on the NASDAQ exchange on Feb 27, 2018. This Canadian based company cultivates medical marijuana companies and owns 100% of Peace Naturals, 100% of Original BC and 21.5% of Whistler Medical Marijuana Company. It doesn’t yet have a Zacks Rank. Stay tuned.
Get The News You Want
There are other biopharmaceuticals that are in the development stages of cannabis-based therapies and treatments. Additionally, some of the large food and beverage companies are looking for ways to invest in cannabis food and drink products.
What other stocks could be marijuana investments in 2018?
Listen to the podcast to find out.
Don’t Even Think About Buying Bitcoin Until You Read This
The most popular cryptocurrency skyrocketed last year, giving some investors the chance to bank 20X returns or even more. Those gains, however, came with serious volatility and risk. Bitcoin sank 25% or more 3 times in 2017.
Zacks’ has just released a new Special Report to help readers capitalize on the explosive profit potential of Bitcoin and the other cryptocurrencies with significantly less volatility than buying them directly.
Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.